5 completed, 1 recruiting. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 5, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow HYQVIA: new trials by email Literature Review of HYQVIA trials Research Report on HYQVIA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) TAK-881, HYQVIA, SC Investigational Needle Sets - Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) | Phase 3 | Recruiting | Takeda | 59 | 2025-05-06 | 2026-01-20 |
| A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases TAK-881, HYQVIA - Primary Immunodeficiency Diseases (PID) | Phase 2 / Phase 3 | Completed | Takeda | 65 | 2023-10-24 | 2026-09-30 |
| Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects HYQVIA - Primary Immunodeficiency Diseases (PID) | Phase 3 | Completed | Baxalta now part of Shire | 44 | 2017-09-25 | 2023-10-23 |
| Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP HYQVIA - Chronic Inflammatory Demyelinating Polyradiculoneuropathy | Phase 3 | Completed | Baxalta now part of Shire | 85 | 2016-11-14 | 2024-08-28 |
| A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) HYQVIA, 0.25% albumin placebo solution with rHuPH20, IGIV GAMMAGARD LIQUID/KIOVIG - Chronic Inflammatory Demyelinating Polyradiculoneuropathy | Phase 3 | Completed | Baxalta now part of Shire | 138 | 2015-12-15 | 2023-05-24 |
| Gammagard Liquid and rHuPH20 in PID Recombinant human hyaluronidase (rHuPH20)+ immune globulin intravenous (IGIV) - Primary Immunodeficiency Diseases (PID) | Phase 3 | Completed | Baxalta now part of Shire | 89 | 2008-12-18 | 2021-05-19 |
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (3) · Primary Immunodeficiency Diseases (3) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Demyelinating Diseases (1) · Immune System Diseases (1) · Nervous System Diseases (1) · Neuromuscular Diseases (1) · Peripheral Nervous System Diseases (1) · Polyneuropathies (1) · Polyradiculoneuropathy (1)
Baxalta now part of Shire (4) · Takeda (2)
United States (6) · Czechia (4) · Denmark (4) · Germany (4) · Poland (4) · Spain (4) · Argentina (3) · Canada (3) · Greece (3) · Italy (3) · Slovakia (3) · Brazil (2) · Colombia (2) · France (2) · Mexico (2)
PMID 42578463, PMID 22846381, PMID 27220317, PMID 34931880, PMID 39523874, PMID 41937917
2014 (1), 2016 (1)